GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (LTS:0RBP) » Definitions » Forward Dividend Yield %

Kiadis Pharma NV (LTS:0RBP) Forward Dividend Yield % : 0.00% (As of May. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Forward Dividend Yield %?

As of today (2024-05-25), the Forward Annual Dividend Yield of Kiadis Pharma NV is 0.00%.

As of today (2024-05-25), the Trailing Annual Dividend Yield of Kiadis Pharma NV is 0.00%.

LTS:0RBP's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.6
* Ranked among companies with meaningful Forward Dividend Yield % only.

Kiadis Pharma NV's Dividends per Share for the six months ended in Dec. 2020 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Kiadis Pharma NV's Forward Dividend Yield %

For the Biotechnology subindustry, Kiadis Pharma NV's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kiadis Pharma NV's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiadis Pharma NV's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Kiadis Pharma NV's Forward Dividend Yield % falls into.



Kiadis Pharma NV Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Kiadis Pharma NV  (LTS:0RBP) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Kiadis Pharma NV Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kiadis Pharma NV (LTS:0RBP) Business Description

Traded in Other Exchanges
N/A
Address
Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP
Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (LTS:0RBP) Headlines

No Headlines